Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Skin Neoplasms × ProMune × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 6 Carcinoma, Non-Small-Cell Lung 6 Breast Neoplasms 3 Uveal Melanoma 2 Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Carcinoma, Renal Cell 2 Carcinoma 2 Waldenstrom Macroglobulinemia 1 Skin Neoplasms 1 Neoplasm Metastasis 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Esophageal Neoplasms 1 Breast Neoplasms, Male 1

Interventions

pembrolizumab 23 Nivolumab 20 aldesleukin 19 Cyclophosphamide 18 Ipilimumab 16 Interleukin-2 15 fludarabine 14 fludarabine phosphate 12 cemiplimab 11 Radiotherapy 7 Biopsy 7 dabrafenib 6 Surveys and Questionnaires 6 Fluorouracil 6 Dacarbazine 6 trametinib 5 binimetinib 5 Vemurafenib 5 Surgical Procedures, Operative 5 Radiation 5 Blood Specimen Collection 5 Aminolevulinic Acid 5 encorafenib 4 Temozolomide 4 Sirolimus 4 Photochemotherapy 4 Educational Status 4 sonidegib 3 montanide ISA 51 3 avelumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00070642 2009-02-10

CPG 7909 Injection in Melanoma

Pfizer

Phase 2 Completed

Carcinoma, Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡